INSIGNEO ADVISORY SERVICES, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1964958
MIAMI, FL
Position in NTLA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$128,584
+$38,415 QoQ
Shares Held
10,030
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INSIGNEO ADVISORY SERVICES, LLC holds $1,928,504 across 10 Biotechnology names. NTLA ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
3,459 | $565,615 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
437 | $337,643 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
656 | $292,930 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
4,538 | $215,872 | |
| 5 | ZURA |
Zura Bio Ltd
|
25,650 | $152,617 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
This page
|
10,030 | $128,584 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
10,000 | $84,700 | |
| 8 | WVE |
Wave Life Sciences Ltd.
|
11,000 | $79,750 |
All Filings in NTLA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $128,584 | 10,030 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $90,169 | 10,030 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||